Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients

Core Insights - Eli Lilly has reduced the price of its weight-loss drug Zepbound for certain out-of-pocket patients and introduced new vial doses [1][4] - The new pricing for Zepbound includes a 2.5-milligram dose at $349 per month and a 5-milligram dose at$499 per month, down from $399 and$549 respectively [1][4] - New 7.5-mg and 10-mg single-use vials are available for $499 when refilled every 45 days through the "Zepbound Self Pay Journey Program" [2][4] Pricing and Availability - The new vials are priced at$599 and $699 if refilled outside the 45-day window [2] - Zepbound is available exclusively through LillyDirect Self Pay Pharmacy Solutions, which aims to provide transparent pricing by eliminating third-party supply chain entities [3] Regulatory and Market Performance - Zepbound is FDA-approved for weight loss and sleep apnea, administered via weekly injections with recommended maintenance doses of 5 mg, 10 mg, or 15 mg [3] - Eli Lilly's fourth-quarter sales for Zepbound fell short of analysts' expectations, despite a 2% increase in shares on the day of the announcement and a 17% rise over the past year [4]